{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:26Z","timestamp":1772165606959,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"China Center for Evidence Based Traditional Chinese Medicine, CCEBTM","award":["2020YJSZX-5"],"award-info":[{"award-number":["2020YJSZX-5"]}]},{"name":"China Center for Evidence Based Traditional Chinese Medicine, CCEBTM","award":["2020YJSZX-5"],"award-info":[{"award-number":["2020YJSZX-5"]}]},{"name":"China Center for Evidence Based Traditional Chinese Medicine, CCEBTM","award":["2020YJSZX-5"],"award-info":[{"award-number":["2020YJSZX-5"]}]},{"name":"Chinese Medicine Development Fund, Hong Kong, China","award":["20B2\/027A"],"award-info":[{"award-number":["20B2\/027A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Integrated traditional Chinese and western medicine (ITCWM), as a representative type of complex intervention, is commonly used for the treatment of angina pectoris (AP) in clinical practice. However, it is unclear whether the details of ITCWM interventions, such as rationale for selection and design, implementation and potential interactions for different therapies, were adequately reported. Therefore, this study aimed to describe the reporting characteristics and quality in randomized controlled trials (RCTs) of AP with ITCWM interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Through a search of 7 electronic databases, we identified RCTs of AP with ITCWM interventions published in both English and Chinese from 1\n                      <jats:sup>st<\/jats:sup>\n                      Jan 2017 to 6\n                      <jats:sup>th<\/jats:sup>\n                      Aug 2022. The general characteristics of included studies were summarized, further, the quality of reporting was assessed based on three Checklists, including the CONSORT with 36 items (except for one item 1b about abstract), the CONSORT for abstracts (17 items), and a self-designed ITCWM-related checklist (21 items covering rationale and details of interventions, outcome assessment and analysis). The quality of RCTs published in English and Chinese, as well as journals and dissertations were also compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 451 eligible RCTs were included. For the reporting compliance, the mean score (95% Confidence Interval) of the CONSORT (72 scores in total), CONSORT for abstract (34 scores in total), and ITCWM-related (42 scores in total) checklists was 27.82 (27.44\u201328.19), 14.17 (13.98\u201314.37) and 21.06 (20.69\u201321.43), respectively. More than half items were evaluated as poor quality (reporting rate\u2009&lt;\u200950%) among each Checklist. Moreover, the reporting quality of publications in English journals was higher than that in Chinese journals in terms of the CONSORT items. The reporting of published dissertations was better than that in journal publications regarding both the CONSORT and ITCWM-specific items.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although the CONSORT appears to have enhanced the reporting of RCTs in AP, the quality of ITCWM specifics is variable and in need of improvement. Reporting guideline of the ITCWM recommendations should be developed thus to improve their quality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12874-023-01953-1","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T05:03:02Z","timestamp":1684818182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reporting quality of randomized controlled trials of angina pectoris with integrated traditional Chinese and western medicine interventions: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiashuai","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Wah","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"1953_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407\u201377.","journal-title":"Eur Heart J"},{"key":"1953_CR2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141:e139-596.","journal-title":"Circulation"},{"key":"1953_CR3","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2021.1527","volume":"325","author":"PH Joshi","year":"2021","unstructured":"Joshi PH, de Lemos JA. Diagnosis and management of stable Angina: a review. JAMA. 2021;325:1765\u201378.","journal-title":"JAMA"},{"key":"1953_CR4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM197906143002402","volume":"300","author":"GA Diamond","year":"1979","unstructured":"Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350\u20138.","journal-title":"N Engl J Med"},{"key":"1953_CR5","doi-asserted-by":"publisher","first-page":"e004080","DOI":"10.1161\/JAHA.116.004080","volume":"5","author":"A Eisen","year":"2016","unstructured":"Eisen A, Bhatt DL, Steg PG, Eagle KA, Goto S, Guo J, et al. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc. 2016;5:e004080.","journal-title":"J Am Heart Assoc"},{"key":"1953_CR6","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archinternmed.2009.295","volume":"169","author":"JF Beltrame","year":"2009","unstructured":"Beltrame JF, Weekes AJ, Morgan C, Tavella R, Spertus JA. The prevalence of weekly angina among patients with chronic stable angina in primary care practices: the Coronary Artery Disease in General Practice (CADENCE) Study. Arch Intern Med. 2009;169:1491\u20139.","journal-title":"Arch Intern Med"},{"key":"1953_CR7","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289\u2013367.","journal-title":"Eur Heart J"},{"key":"1953_CR8","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.jacc.2020.08.078","volume":"76","author":"R Ferraro","year":"2020","unstructured":"Ferraro R, Latina JM, Alfaddagh A, Michos ED, Blaha MJ, Jones SR, et al. Evaluation and management of patients with stable angina: beyond the Ischemia Paradigm: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;76:2252\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"1953_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/CIRCOUTCOMES.108.775247","volume":"1","author":"EM Mahoney","year":"2008","unstructured":"Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, et al. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2008;1:38\u201345.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1953_CR10","first-page":"43","volume":"37","author":"SP Liu","year":"2022","unstructured":"Liu SP. Significance and application of economics research on traditional Chinese medicine. China Economist. 2022;37:43\u20136.","journal-title":"China Economist"},{"key":"1953_CR11","first-page":"CD004468","volume":"2010","author":"Q Zhuo","year":"2010","unstructured":"Zhuo Q, Yuan Z, Chen H, Wu T. Traditional Chinese herbal products for stable angina. Cochrane Database Syst Rev. 2010;2010:CD004468.","journal-title":"Cochrane Database Syst Rev"},{"key":"1953_CR12","first-page":"135","volume":"92","author":"X Zuo","year":"2021","unstructured":"Zuo X, Shi X, Gao X, Lai R, Liu P, Zhao Z. A retrospective study on 221 patients with granulomatous lobular mastitis treated by a combination of traditional Chinese medicine and western medicine. Ann Ital Chir. 2021;92:135\u201341.","journal-title":"Ann Ital Chir"},{"key":"1953_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11655-019-3154-z","volume":"26","author":"P Liao","year":"2020","unstructured":"Liao P, Chen K-J, Ge J-B, Zhang M-Z, Clinical Practice Guideline of Integrative Chinese and Western Medicine for Acute Myocardial Infarction Working Group. Clinical Practice Guideline of Integrative Chinese and Western Medicine for Acute Myocardial Infarction. Chin J Integr Med. 2020;26:539\u201351.","journal-title":"Chin J Integr Med"},{"key":"1953_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1142\/S0192415X20500378","volume":"48","author":"KW Chan","year":"2020","unstructured":"Chan KW, Wong VT, Tang SCW. COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med. 2020;48:737\u201362.","journal-title":"Am J Chin Med"},{"key":"1953_CR15","unstructured":"Fan JH. Analysis on the historical formation process of the policy of \u201cuniting Chinese and Western Medicine.\u201d Guangzhou Univ of Chin Med (Chin). Guangzhou: Dissertation; 2014."},{"key":"1953_CR16","first-page":"55","volume":"34","author":"Yantai Infectious Disease Hospital of Shandong Province, 407 Hospital of the People\u2019s Liberation Army","year":"1994","unstructured":"Yantai Infectious Disease Hospital of Shandong Province, 407 Hospital of the People\u2019s Liberation Army. Yangxin Shugan Decoction for treating 160 cases of Angina pectoris of coronary heart disease. Chinese J Med (Chin). 1994;34:55\u20136.","journal-title":"Chinese J Med (Chin)."},{"key":"1953_CR17","first-page":"97","volume":"26","author":"GX Cai","year":"2010","unstructured":"Cai GX, Yan X, Ning ZP, Chen ZP, Tan Y, Shen J, et al. International Standard for TCM Syndrome Treatment of Common internal Diseases (Draft) Coronary Heart disease Angina pectoris. Hunan J Trad Chin Med (Chin). 2010;26:97\u20139.","journal-title":"Hunan J Trad Chin Med (Chin)"},{"key":"1953_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","volume":"15","author":"R Ferrari","year":"2018","unstructured":"Ferrari R, Camici PG, Crea F, Danchin N, Fox K, Maggioni AP, et al. Expert consensus document: a \u201cdiamond\u201d approach to personalized treatment of angina. Nat Rev Cardiol. 2018;15:120\u201332.","journal-title":"Nat Rev Cardiol"},{"key":"1953_CR19","first-page":"447","volume":"59","author":"J Wang","year":"2018","unstructured":"Wang J, Chen G. Expert consensus on TCM diagnosis and treatment of stable angina pectoris of coronary heart disease. J Tradit Chin Med (Chin). 2018;59:447\u201350.","journal-title":"J Tradit Chin Med (Chin)"},{"key":"1953_CR20","first-page":"4","volume":"24","author":"Society of Cardiovascular Diseases, China Association of Chinese Medicine","year":"2018","unstructured":"Society of Cardiovascular Diseases, China Association of Chinese Medicine. Traditional Chinese Medicine Treatment Guidelines on Coronary Heart Disease Before and After Percutaneous Coronary Intervention. Chin J Exp Tradit Med Formul (Chin). 2018;24:4\u20136.","journal-title":"Chin J Exp Tradit Med Formul (Chin)"},{"key":"1953_CR21","first-page":"1880","volume":"60","author":"CVD Branch, Chinese Association of Traditional Chinese Medicine","year":"2019","unstructured":"CVD Branch, Chinese Association of Traditional Chinese Medicine. Guidelines for TCM diagnosis and treatment of stable angina pectoris of coronary heart disease. J Tradit Chin Med (Chin). 2019;60:1880\u201390.","journal-title":"J Tradit Chin Med (Chin)"},{"key":"1953_CR22","first-page":"1298","volume":"40","author":"CVD Branch, World Federation of Chinese Medicine Societies, CVD Branch, Chinese Association of Integrative Medicine, Intervention CVD Branch, Chinese Association of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Cardiology","year":"2020","unstructured":"CVD Branch, World Federation of Chinese Medicine Societies, CVD Branch, Chinese Association of Integrative Medicine, Intervention CVD Branch, Chinese Association of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Cardiology. Guidelines for the diagnosis and treatment of angina pectoris after coronary revascularization with integrated Traditional Chinese and Western Medicine. Chin J Integr Tradit Western Med (Chin). 2020;40:1298\u2013307.","journal-title":"Chin J Integr Tradit Western Med (Chin)"},{"key":"1953_CR23","first-page":"695","volume":"63","author":"RF Zhang","year":"2022","unstructured":"Zhang RF, Su H, Huang XS, Jia M, Zhang XF, Jia TT, et al. Expert consensus on the diagnosis and treatment of unstable angina pectoris. J Tradit Chin Med (Chin). 2022;63:695\u2013700.","journal-title":"J Tradit Chin Med (Chin)"},{"key":"1953_CR24","first-page":"CD004473","volume":"2008","author":"X Duan","year":"2008","unstructured":"Duan X, Zhou L, Wu T, Liu G, Qiao J, Wei J, et al. Chinese herbal medicine Suxiao Jiuxin wan for angina pectoris. Cochrane Database Syst Rev. 2008;2008:CD004473.","journal-title":"Cochrane Database Syst Rev"},{"key":"1953_CR25","first-page":"CD004474","volume":"2006","author":"T Wu","year":"2006","unstructured":"Wu T, Harrison RA, Chen X, Ni J, Zhou L, Qiao J, et al. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Syst Rev. 2006;2006:CD004474.","journal-title":"Cochrane Database Syst Rev"},{"key":"1953_CR26","first-page":"2710","volume":"22","author":"LP Chen","year":"2020","unstructured":"Chen LP, Yao JP, Chen J, Zhao L, Liang FR. Quality evaluation of domestic literature reports on randomized controlled trial of acupuncture treatment of angina pectoris. Modern Tradit Chin Med Materia Med-World Sci Technol (Chin). 2020;22:2710\u20136.","journal-title":"Modern Tradit Chin Med Materia Med-World Sci Technol (Chin)"},{"key":"1953_CR27","first-page":"258","volume":"3","author":"LK Zhou","year":"2004","unstructured":"Zhou LK, Duan X, An N, Wu TX, Liu GJ. Quality assessement on the studies of traditional Chinese Medicine for Coronary Heart Disease Angina. Chin J Evid Based Med (Chin). 2004;3:258\u201362+266.","journal-title":"Chin J Evid Based Med (Chin)"},{"key":"1953_CR28","first-page":"70","volume":"31","author":"LL Zhang","year":"2015","unstructured":"Zhang LL, Zhang J, Li DH, Zhao L, Liang FR. Quality evaluation of randomized controlled trials in the treatment of point application therapy for stable Angina pectoris. J Clin Acupunct Moxibustion (Chin). 2015;31:70\u20133.","journal-title":"J Clin Acupunct Moxibustion (Chin)"},{"key":"1953_CR29","first-page":"1","volume":"17","author":"C Xue","year":"2016","unstructured":"Xue C, Wang J, He JL, Wang F. Evaluate the document quality on randomized controlled trials of Danhong injection and Danshen injection in the treatment of angina pectoris of coronary heart disease using CONSORT standard. J Shanxi Univ Chin Med (Chin). 2016;17:1\u20133.","journal-title":"J Shanxi Univ Chin Med (Chin)"},{"key":"1953_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/M16-2977","volume":"167","author":"CW Cheng","year":"2017","unstructured":"Cheng CW, Wu TX, Shang HC, Li YP, Altman DG, Moher D, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med. 2017;167:112\u201321.","journal-title":"Ann Intern Med"},{"key":"1953_CR31","volume-title":"A Guide to the core journal of China","author":"JL Chen","year":"2021","unstructured":"Chen JL, Zhang JE, Cai RH. A Guide to the core journal of China. Beijing: Peking University Press; 2021."},{"key":"1953_CR32","volume-title":"2021 Chinese S&T Citation Reports (Natural Science)","author":"Institute of Scientific and Technical Information of China","year":"2021","unstructured":"Institute of Scientific and Technical Information of China. 2021 Chinese S&T Citation Reports (Natural Science). Beijing: Scientific and Technical Documentation Press; 2021."},{"key":"1953_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","volume":"10","author":"D Moher","year":"2012","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, G\u00f8tzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28\u201355.","journal-title":"Int J Surg"},{"key":"1953_CR34","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1371\/journal.pmed.0050020","volume":"5","author":"S Hopewell","year":"2008","unstructured":"Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008;5:e20.","journal-title":"PLoS Med"},{"key":"1953_CR35","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360\u20133.","journal-title":"Fam Med"},{"key":"1953_CR36","doi-asserted-by":"publisher","first-page":"2106627","DOI":"10.1080\/20016689.2022.2106627","volume":"10","author":"W Margas","year":"2022","unstructured":"Margas W, Wojciechowski P, Toumi M. Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis. J Mark Access Health Policy. 2022;10:2106627.","journal-title":"J Mark Access Health Policy"},{"key":"1953_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/dx-2013-0029","volume":"1","author":"ES Holmboe","year":"2014","unstructured":"Holmboe ES, Durning SJ. Assessing clinical reasoning: moving from in vitro to in vivo. Diagnosis (Berl). 2014;1:111\u20137.","journal-title":"Diagnosis (Berl)"},{"key":"1953_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11655-022-2889-0","volume":"28","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Xu H. Formulation and interpretation of international diagnostic guidelines for blood-stasis syndrome. Chin J Integr Med. 2022;28:291\u20136.","journal-title":"Chin J Integr Med"},{"key":"1953_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1745-6215-12-98","volume":"12","author":"D Moher","year":"2011","unstructured":"Moher D, Hopewell S, Schulz KF, Altman DG. Resources for authors of reports of randomized trials: harnessing the wisdom of authors, editors, and readers. Trials. 2011;12:98.","journal-title":"Trials"},{"key":"1953_CR40","doi-asserted-by":"publisher","first-page":"4308380","DOI":"10.1155\/2020\/4308380","volume":"2020","author":"G Qian","year":"2020","unstructured":"Qian G, Zeng J, Lu L, Pei W, Liu K, Luo Z, et al. Evaluation of reporting quality in randomised controlled trials of acupuncture for acute herpes zoster by the CONSORT statement and STRICTA guidelines. Evid Based Complement Alternat Med. 2020;2020:4308380.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1953_CR41","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.clinthera.2007.07.023","volume":"29","author":"G Wang","year":"2007","unstructured":"Wang G, Mao B, Xiong Z-Y, Fan T, Chen X-D, Wang L, et al. The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China. Clin Ther. 2007;29:1456\u201367.","journal-title":"Clin Ther"},{"key":"1953_CR42","first-page":"651","volume":"18","author":"R Tian","year":"2018","unstructured":"Tian R, Zhao C, Zheng SH, Lin WQ, Yang Z, Wu TX, et al. Constructing the Chinese medicine clinical curative effects research report system. Chin J Evid Based Med (Chin). 2018;18:651\u20133.","journal-title":"Chin J Evid Based Med (Chin)"},{"key":"1953_CR43","first-page":"12","volume":"37","author":"JG Alspach","year":"2017","unstructured":"Alspach JG. Writing for publication 101: why the abstract is so important. Crit Care Nurse. 2017;37:12\u20135.","journal-title":"Crit Care Nurse"},{"key":"1953_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13020-021-00475-6","volume":"16","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang L, Xiong W, Wang X, Zhou X, Zhao C, et al. Assessment of the reporting quality of randomised controlled trials of massage. Chin Med. 2021;16:64.","journal-title":"Chin Med"},{"key":"1953_CR45","doi-asserted-by":"publisher","first-page":"e005068","DOI":"10.1136\/bmjopen-2014-005068","volume":"4","author":"KH Kim","year":"2014","unstructured":"Kim KH, Kang JW, Lee MS, Lee J-D. Assessment of the quality of reporting in randomised controlled trials of acupuncture in the Korean literature using the CONSORT statement and STRICTA guidelines. BMJ Open. 2014;4:e005068.","journal-title":"BMJ Open"},{"key":"1953_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/2046-4053-1-60","volume":"1","author":"L Turner","year":"2012","unstructured":"Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review Syst Rev. 2012;1:60.","journal-title":"A Cochrane review Syst Rev"},{"key":"1953_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2288-11-110","volume":"11","author":"JL Wang","year":"2011","unstructured":"Wang JL, Sun TT, Lin YW, Lu R, Fang JY. Methodological reporting of randomized controlled trials in major hepato-gastroenterology journals in 2008 and 1998: a comparative study. BMC Med Res Methodol. 2011;11:110.","journal-title":"BMC Med Res Methodol"},{"key":"1953_CR48","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1142\/S0192415X21500610","volume":"49","author":"Y Duan","year":"2021","unstructured":"Duan Y, Xu Z, Lin Y, Miao J, Chen J, Guo H, et al. A scoping review of cross-sectional studies on traditional Chinese medicine. Am J Chin Med. 2021;49:1275\u201396.","journal-title":"Am J Chin Med"},{"key":"1953_CR49","unstructured":"EQUATOR Network. Guidelines for Reporting Clinical Trials on Integrated Chinese and Western Medicine. 2023. Accessed at: https:\/\/www.equator-network.org\/library\/reporting-guidelines-under-development\/reporting-guidelines-under-development-for-clinical-trials\/#INTEGRATE."}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-023-01953-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-023-01953-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-023-01953-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T06:04:30Z","timestamp":1684821870000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-023-01953-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1953"],"URL":"https:\/\/doi.org\/10.1186\/s12874-023-01953-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2482375\/v1","asserted-by":"object"}]},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}